CIP2A and neoplasm: While there is a general lack of studies on the predictive potential of CIP2A expression in EC models, it is very likely that, based upon the evidence obtained in other solid (gynecologic) tumors, CIP2A expression could mediate therapeutic resistance in EC cells as well.